Showing results (11-20 of 320) with videos related to
Sort By:
Pageof 32
European Journal of Heart Failure|February 29, 2008
Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patientsRoman Pfister, Holger Diedrichs, Anne Schiedermair, et al.Indian Heart Journal|December 25, 2010
Safety and tolerability of beta-blockers: prejudices & realityErland ErdmannDeutsche Medizinische Wochenschrift (1946)|August 26, 2015
[What is the use of even lower LDL cholesterol by combination therapy? A critical viewpoint]Erland ErdmannDrugs of Today (Barcelona, Spain : 1998)|January 25, 2007
Worldwide spread of lifestyle diseases and its importance for cardiovascular eventsErland ErdmannCurrent Cardiology Reports|June 5, 2007
The problem of polypharmacy in heart failureMarkus Flesch, Erland ErdmannMedizinische Klinik (Munich, Germany : 1983)|January 16, 2007
[Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice]Fikret Er, Erland ErdmannEuropean Heart Journal|January 3, 2008
Weighing up the cardiovascular benefits of thiazolidinedione therapy: the impact of increased risk of heart failureErland Erdmann, Robert G WilcoxJournal of Diabetes|October 7, 2010
Pioglitazone and the risk of cardiovascular events in patients with Type 2 diabetes receiving concomitant treatment with nitrates, renin-angiotensin system blockers, or insulin: results from the PROactive study (PROactive 20)Erland Erdmann, Robert Spanheimer, Bernard Charbonnel, et al.Plos One|December 29, 2010
Informed consent prior to coronary angiography in a real world scenario: what do patients remember?Aslihan Eran, Erland Erdmann, Fikret ErCurrent Cardiology Reviews|August 3, 2010
Thiazolidinediones and cardiovascular risk - a question of balanceErland Erdmann, Bernard Charbonnel, Robert WilcoxPageof 32